[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Mr. Manmeet Singh Soni CPA", "age": 46, "title": "COO, CFO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1261021, "exercisedValue": 0, "unexercisedValue": 107858016}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shelley D. Spray", "age": 59, "title": "Chief Education & Brand Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura Q. M. Chow M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.42, "open": 24.38, "dayLow": 23.63, "dayHigh": 24.42, "regularMarketPreviousClose": 24.42, "regularMarketOpen": 24.38, "regularMarketDayLow": 23.63, "regularMarketDayHigh": 24.42, "payoutRatio": 0.0, "beta": -1.06, "forwardPE": -62.368423, "volume": 2431355, "regularMarketVolume": 2431355, "averageVolume": 3735739, "averageVolume10days": 3199020, "averageDailyVolume10Day": 3199020, "bid": 23.62, "ask": 23.78, "bidSize": 4, "askSize": 4, "marketCap": 17605474304, "fiftyTwoWeekLow": 11.76, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 25.455, "twoHundredDayAverage": 21.984526, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17313146880, "profitMargins": 0.0, "floatShares": 116181220, "sharesOutstanding": 742846976, "sharesShort": 29812741, "sharesShortPriorMonth": 28557957, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0401, "heldPercentInsiders": 0.84300005, "heldPercentInstitutions": 0.13565, "shortRatio": 10.5, "shortPercentOfFloat": 0.2552, "impliedSharesOutstanding": 765414016, "bookValue": 0.349, "priceToBook": 67.90831, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -746078016, "trailingEps": -1.01, "forwardEps": -0.38, "enterpriseToEbitda": -22.805, "52WeekChange": 0.88095236, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 23.7, "targetHighPrice": 50.07088, "targetLowPrice": 12.08263, "targetMeanPrice": 33.872585, "targetMedianPrice": 34.965233, "recommendationMean": 1.53846, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 297872000, "totalCashPerShare": 0.401, "ebitda": -759176000, "totalDebt": 5553000, "quickRatio": 4.938, "currentRatio": 5.126, "debtToEquity": 2.14, "returnOnAssets": -1.4253, "returnOnEquity": -3.28297, "freeCashflow": 41463624, "operatingCashflow": -206882000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Summit Therapeutics Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1756511958, "regularMarketTime": 1756497600, "regularMarketChangePercent": -2.9484, "regularMarketPrice": 23.7, "postMarketChangePercent": 0.253162, "postMarketPrice": 23.76, "postMarketChange": 0.0599995, "regularMarketChange": -0.719999, "regularMarketDayRange": "23.63 - 24.42", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3735739, "fiftyTwoWeekLowChange": 11.940001, "fiftyTwoWeekLowChangePercent": 1.0153061, "fiftyTwoWeekRange": "11.76 - 36.91", "fiftyTwoWeekHighChange": -13.209999, "fiftyTwoWeekHighChangePercent": -0.35789758, "fiftyTwoWeekChangePercent": 88.09524, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.01, "epsForward": -0.38, "epsCurrentYear": -0.687, "priceEpsCurrentYear": -34.497818, "fiftyDayAverageChange": -1.7549992, "fiftyDayAverageChangePercent": -0.06894516, "twoHundredDayAverageChange": 1.7154751, "twoHundredDayAverageChangePercent": 0.078031026, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-08-29", "averageAnalystRating": "1.5 - Buy", "longName": "Summit Therapeutics Inc.", "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]